This is a Validated Antibody Database (VAD) review about human TRB, based on 54 published articles (read how Labome selects the articles), using TRB antibody in all methods. It is aimed to help Labome visitors find the most suited TRB antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TRB synonym: TCRB; TRB@

Invitrogen
mouse monoclonal (8A3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3d
Invitrogen TRB antibody (Thermo Fisher, 8A3) was used in immunohistochemistry - paraffin section on human samples (fig 3d). Proc Natl Acad Sci U S A (2022) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig s14b
Invitrogen TRB antibody (eBioscience, IP26) was used in flow cytometry on human samples (fig s14b). Science (2019) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; fig 7a
Invitrogen TRB antibody (eBiosciences, 12-9986-42) was used in flow cytometry on human samples (fig 7a). Cell (2018) ncbi
mouse monoclonal (8A3)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to present patient cases of nasal natural killer/T cell tumors in the central nervous system, Invitrogen TRB antibody (Thermo Fisher Scientific, TCR1151) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Histopathology (2017) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig 2c
In order to define the contribution of CD103+ tumor-infiltrating lymphocytes to high-grade serous epithelial ovarian cancer, Invitrogen TRB antibody (eBioscience, IP26) was used in flow cytometry on human samples (fig 2c). Oncotarget (2016) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...
In order to find a role for Car enzymes in regulating mast cell lineage commitment, Invitrogen TRB antibody (eBioscience, IP26) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig 2E
In order to study the contribution of CXCR6/CXCL16 interactions in glycolipid-dependent invariant natural killer cell activation and tumor control, Invitrogen TRB antibody (eBioscience, IP26) was used in flow cytometry on human samples (fig 2E). Oncoimmunology (2016) ncbi
mouse monoclonal (AMKB1-2)
  • flow cytometry; mouse; fig s1
In order to develop a novel mouse model to test the mechanisms mediating transformation of chronic inflammation into fibrosis, Invitrogen TRB antibody (ebioscience, MR10-2) was used in flow cytometry on mouse samples (fig s1). PLoS ONE (2016) ncbi
mouse monoclonal (8F10)
  • flow cytometry; human; fig 5a
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, Invitrogen TRB antibody (Endogene, 8F10) was used in flow cytometry on human samples (fig 5a). Cell Mol Immunol (2017) ncbi
mouse monoclonal (8A3)
  • immunocytochemistry; human; 1:100; fig 1a
In order to identify alpha beta T cell receptor expression as a characteristic feature of macrophages in the tumor microenvironment, Invitrogen TRB antibody (Pierce-Endogen, 8A3) was used in immunocytochemistry on human samples at 1:100 (fig 1a). Immunobiology (2017) ncbi
mouse monoclonal (8A3)
  • immunohistochemistry; human; 1:100; fig 3
In order to study idelalisib-associated enterocolitis in patients with chronic lymphocytic leukemia or follicular lymphoma, Invitrogen TRB antibody (Thermo Fisher, 8A3) was used in immunohistochemistry on human samples at 1:100 (fig 3). Am J Surg Pathol (2015) ncbi
mouse monoclonal (8A3)
  • immunoprecipitation; human; fig 1
In order to study the assembly of the alphabetaTCR, Invitrogen TRB antibody (Thermo Fisher Scientific, TCR1151) was used in immunoprecipitation on human samples (fig 1). J Biol Chem (2015) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; fig 4
In order to discuss the role of T cells in Rasmussen encephalitis, Invitrogen TRB antibody (eBioscience, IP26) was used in flow cytometry on human samples (fig 4). J Neuroinflammation (2015) ncbi
mouse monoclonal (8A3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to study the characteristics of lymphomatoid gastropathy, Invitrogen TRB antibody (Thermo Scientific, 8A3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Am J Surg Pathol (2015) ncbi
mouse monoclonal (8A3)
  • immunohistochemistry - paraffin section; human
In order to describe the clinicopathological features of 15 patients with Epstein-Barr virus-positive nodal T/NK-cell lymphoma, Invitrogen TRB antibody (Thermo Scientific, 8A3) was used in immunohistochemistry - paraffin section on human samples . Hum Pathol (2015) ncbi
mouse monoclonal (8A3)
  • immunohistochemistry - paraffin section; human
Invitrogen TRB antibody (Thermo Scientific, 8A3) was used in immunohistochemistry - paraffin section on human samples . J Cutan Pathol (2015) ncbi
mouse monoclonal (8A3)
  • immunohistochemistry; human; 1:100
Invitrogen TRB antibody (Thermo Fisher Scientific, 8A3) was used in immunohistochemistry on human samples at 1:100. J Cutan Pathol (2015) ncbi
mouse monoclonal (8A3)
  • immunohistochemistry - paraffin section; human; 1:50
In order to study the clinicopathologic features of extranodal natural killer/T-cell lymphoma, nasal type, Invitrogen TRB antibody (Thermo Scientific, TCR1151) was used in immunohistochemistry - paraffin section on human samples at 1:50. Am J Surg Pathol (2015) ncbi
mouse monoclonal (8A3)
  • immunohistochemistry - paraffin section; human; 1:50
In order to examine the use of latent membrane protein 1, cutaneous lymphocyte antigen, and cell origin as biomarkers in patients with nasal natural killer (NK)/T-cell lymphoma treated with concurrent chemoradiotherapy, Invitrogen TRB antibody (Thermo Scientific, TCR1151) was used in immunohistochemistry - paraffin section on human samples at 1:50. Cancer Sci (2014) ncbi
mouse monoclonal (8A3)
  • immunohistochemistry - paraffin section; human; 1:40
In order to determine if the presence of the DUSP22-IRF4 translocation is a distinctive histological features in patients with cutaneous anaplastic large cell lymphoma, Invitrogen TRB antibody (Thermo Scientific, 8A3) was used in immunohistochemistry - paraffin section on human samples at 1:40. Histopathology (2015) ncbi
mouse monoclonal (8A3)
  • immunohistochemistry - paraffin section; human; 1:50
Invitrogen TRB antibody (Thermo Scientific, 8A3) was used in immunohistochemistry - paraffin section on human samples at 1:50. Cancer Sci (2014) ncbi
mouse monoclonal (8A3)
  • immunohistochemistry - paraffin section; human; 3 ug/ml; loading ...; fig 4
In order to characterize stroma cells and ductal epithelium comparing chronic pancreatitis and pancreatic ductal adenocarcinoma, Invitrogen TRB antibody (Thermo, gamma3.20) was used in immunohistochemistry - paraffin section on human samples at 3 ug/ml (fig 4). PLoS ONE (2014) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human
Invitrogen TRB antibody (e-Biosciences, IP26) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
mouse monoclonal (8A3)
  • ELISA; human; 1:1500
In order to develop a model for predicting TCR-peptide-MHC class I structures, Invitrogen TRB antibody (Pierce, TCR1151) was used in ELISA on human samples at 1:1500. PLoS ONE (2011) ncbi
mouse monoclonal (8A3)
  • immunohistochemistry; human; fig 3
In order to study subcutaneous panniculitis-like T-cell lymphomas in Korean patients, Invitrogen TRB antibody (Thermo Scientific, 8A3) was used in immunohistochemistry on human samples (fig 3). Ann Dermatol (2011) ncbi
BioLegend
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig 1b
BioLegend TRB antibody (BioLegend, IP26) was used in flow cytometry on human samples (fig 1b). Proc Natl Acad Sci U S A (2022) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig 1c
BioLegend TRB antibody (Biolegend, 306722) was used in flow cytometry on human samples (fig 1c). Biomark Res (2022) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human
BioLegend TRB antibody (Biolegend, IP26) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (IP26)
  • other; human; loading ...; fig 7a
  • immunocytochemistry; human; loading ...; fig 7a
BioLegend TRB antibody (BioLegend, IP26) was used in other on human samples (fig 7a) and in immunocytochemistry on human samples (fig 7a). elife (2019) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig 1a
BioLegend TRB antibody (BioLegend, 306722) was used in flow cytometry on human samples (fig 1a). Cell (2019) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; fig 2a
BioLegend TRB antibody (Biolegend, IP26) was used in flow cytometry on human samples (fig 2a). Cell Stem Cell (2019) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; 1:300; loading ...; fig s1a
BioLegend TRB antibody (Biolegend, IP26) was used in flow cytometry on human samples at 1:300 (fig s1a). Nat Commun (2018) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; fig s2e
BioLegend TRB antibody (BioLegend, 306708) was used in flow cytometry on human samples (fig s2e). Cell (2018) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig st1
In order to investigate the effect of PD-1 expression on phagocytosis and tumour immunity, BioLegend TRB antibody (Biolegend, IP26) was used in flow cytometry on human samples (fig st1). Nature (2017) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; 1:50; loading ...; fig 2a
In order to measure CD11d expression on lymphocyte subsets using flow cytometry, BioLegend TRB antibody (BioLegend, IP26) was used in flow cytometry on human samples at 1:50 (fig 2a). J Leukoc Biol (2017) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize CD8 positive alpha beta gamma delta T cells, BioLegend TRB antibody (BioLegend, IP26) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (IP26)
  • immunocytochemistry; human; loading ...; fig 4
BioLegend TRB antibody (BioLegend, IP26) was used in immunocytochemistry on human samples (fig 4). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; 1:400; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend TRB antibody (Biolegend, IP26) was used in flow cytometry on human samples at 1:400 (tbl s2). Nat Immunol (2016) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; loading ...; fig 1c
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend TRB antibody (biolegend, IP26) was used in flow cytometry on human samples (fig 1c). J Immunol (2016) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human; fig 3
In order to evaluate the therapeutic potential of a gammatheta T cell-targeting tribody for tumor immunotherapy, BioLegend TRB antibody (Biolegend, #306706) was used in flow cytometry on human samples (fig 3). Cell Immunol (2015) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human
BioLegend TRB antibody (Biolegend, 306706) was used in flow cytometry on human samples . Scand J Immunol (2015) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human
BioLegend TRB antibody (BioLegend, IP26) was used in flow cytometry on human samples . Clin Immunol (2015) ncbi
mouse monoclonal (IP26)
  • flow cytometry; human
BioLegend TRB antibody (BioLegend, IP26) was used in flow cytometry on human samples . Nat Med (2014) ncbi
Abcam
hamsters monoclonal
  • immunoprecipitation; mouse; loading ...; fig 4b
Abcam TRB antibody (eBioscience, ab25336) was used in immunoprecipitation on mouse samples (fig 4b). Front Immunol (2018) ncbi
Beckman Coulter
mouse monoclonal (IMMU 546)
  • flow cytometry; mouse; 1:20; loading ...; fig 1c
Beckman Coulter TRB antibody (Beckman Coulter, IMMU 546) was used in flow cytometry on mouse samples at 1:20 (fig 1c). J Clin Invest (2019) ncbi
mouse monoclonal (IMMU 546)
  • flow cytometry; human; loading ...; fig s4b
Beckman Coulter TRB antibody (Beckman Coulter, IMMU 546) was used in flow cytometry on human samples (fig s4b). Sci Immunol (2018) ncbi
mouse monoclonal (E17.5F3.15.13)
  • flow cytometry; human; loading ...; fig s1a
Beckman Coulter TRB antibody (Beckman Coulter, E17.5F3.15.13) was used in flow cytometry on human samples (fig s1a). Nat Med (2018) ncbi
mouse monoclonal (IMMU 222)
  • flow cytometry; human; loading ...; fig s1c
Beckman Coulter TRB antibody (Beckman Coulter, IMMU 222) was used in flow cytometry on human samples (fig s1c). Nat Med (2018) ncbi
mouse monoclonal (CH92)
  • flow cytometry; human; loading ...; fig s1a
Beckman Coulter TRB antibody (Beckman Coulter, CH92) was used in flow cytometry on human samples (fig s1a). Nat Med (2018) ncbi
mouse monoclonal (FIN9)
  • immunohistochemistry - frozen section; domestic rabbit; loading ...; fig 2e
Beckman Coulter TRB antibody (Beckman Coulter, FIN9) was used in immunohistochemistry - frozen section on domestic rabbit samples (fig 2e). J Clin Invest (2017) ncbi
mouse monoclonal (IMMU 157)
  • immunohistochemistry - frozen section; human; loading ...; fig 2b
Beckman Coulter TRB antibody (Beckman Coulter, IMMU157) was used in immunohistochemistry - frozen section on human samples (fig 2b). J Clin Invest (2017) ncbi
mouse monoclonal (E17.5F3.15.13)
  • flow cytometry; human; loading ...; fig s1a
In order to detail MAIT cell responses to various microorganisms and cytokines, Beckman Coulter TRB antibody (Beckman Coulter, E17.5F3.15.13) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (H132)
  • flow cytometry; human; loading ...; fig s1a
In order to detail MAIT cell responses to various microorganisms and cytokines, Beckman Coulter TRB antibody (Beckman Coulter, H132) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (CH92)
  • flow cytometry; human; loading ...; fig s1a
In order to detail MAIT cell responses to various microorganisms and cytokines, Beckman Coulter TRB antibody (Beckman Coulter, CH92) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (MPB2D5)
  • flow cytometry; human; loading ...; fig s1a
In order to detail MAIT cell responses to various microorganisms and cytokines, Beckman Coulter TRB antibody (Beckman Coulter, MPB2D5) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (ELL1.4)
  • flow cytometry; human; loading ...; fig s1a
In order to detail MAIT cell responses to various microorganisms and cytokines, Beckman Coulter TRB antibody (Beckman Coulter, ELL1.4) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (56C5.2)
  • flow cytometry; human; loading ...; fig s1a
In order to detail MAIT cell responses to various microorganisms and cytokines, Beckman Coulter TRB antibody (Beckman Coulter, 56C5.2) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (IMMU 222)
  • flow cytometry; human; loading ...; fig s1a
In order to detail MAIT cell responses to various microorganisms and cytokines, Beckman Coulter TRB antibody (Beckman Coulter, IMMU 222) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (ZIZOU4)
  • flow cytometry; human; loading ...; fig s1a
In order to detail MAIT cell responses to various microorganisms and cytokines, Beckman Coulter TRB antibody (Beckman Coulter, Zizou4) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (JU74.3)
  • flow cytometry; human; loading ...; fig s1a
In order to detail MAIT cell responses to various microorganisms and cytokines, Beckman Coulter TRB antibody (Beckman Coulter, JU74.3) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (C21)
  • flow cytometry; human; loading ...; fig 1d
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, Beckman Coulter TRB antibody (Beckman Coulter, C21) was used in flow cytometry on human samples (fig 1d). J Clin Invest (2017) ncbi
mouse monoclonal (CAS1.1.3)
  • flow cytometry; human; fig 3b
In order to generate T cells from cord blood hematopoietic progenitor cells transduced to express an antigen receptor as assess their ability to limit malignant cells and graft versus host disease, Beckman Coulter TRB antibody (Beckman Coulter, IM2047) was used in flow cytometry on human samples (fig 3b). Oncoimmunology (2017) ncbi
mouse monoclonal (BA62.6)
  • flow cytometry; human; fig 1b
Beckman Coulter TRB antibody (Beckmann-Coulter, BA62.6) was used in flow cytometry on human samples (fig 1b). Sci Rep (2016) ncbi
mouse monoclonal (MPB2D5)
  • flow cytometry; human; fig 1b
Beckman Coulter TRB antibody (Beckmann-Coulter, MPB2D5) was used in flow cytometry on human samples (fig 1b). Sci Rep (2016) ncbi
mouse monoclonal (C21)
  • flow cytometry; human; fig s4a
Beckman Coulter TRB antibody (Beckman Coulter, C21) was used in flow cytometry on human samples (fig s4a). J Immunol (2016) ncbi
mouse monoclonal (JU74.3)
  • flow cytometry; human; fig 5a
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, Beckman Coulter TRB antibody (Immunotech, JU74.3) was used in flow cytometry on human samples (fig 5a). Cell Mol Immunol (2017) ncbi
rat monoclonal (BL37.2)
  • flow cytometry; human; fig 5a
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, Beckman Coulter TRB antibody (Immunotech, BL37.2) was used in flow cytometry on human samples (fig 5a). Cell Mol Immunol (2017) ncbi
mouse monoclonal (IG125)
  • flow cytometry; human; fig 5a
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, Beckman Coulter TRB antibody (Immunotech, IG125) was used in flow cytometry on human samples (fig 5a). Cell Mol Immunol (2017) ncbi
mouse monoclonal (C21)
  • flow cytometry; human; fig 5a
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, Beckman Coulter TRB antibody (Immunotech, C21) was used in flow cytometry on human samples (fig 5a). Cell Mol Immunol (2017) ncbi
mouse monoclonal (IMMU 222)
  • flow cytometry; human; fig 5a
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, Beckman Coulter TRB antibody (Immunotech, IMMU222) was used in flow cytometry on human samples (fig 5a). Cell Mol Immunol (2017) ncbi
mouse monoclonal (56C5.2)
  • flow cytometry; human; fig 5a
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, Beckman Coulter TRB antibody (Immunotech, 56C5.2) was used in flow cytometry on human samples (fig 5a). Cell Mol Immunol (2017) ncbi
mouse monoclonal (TAMAYA1.2)
  • flow cytometry; human; fig 5a
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, Beckman Coulter TRB antibody (Immunotech, TAMAYA1.2) was used in flow cytometry on human samples (fig 5a). Cell Mol Immunol (2017) ncbi
mouse monoclonal (36213)
  • flow cytometry; human; fig 5a
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, Beckman Coulter TRB antibody (Immunotech, 36213) was used in flow cytometry on human samples (fig 5a). Cell Mol Immunol (2017) ncbi
mouse monoclonal (ELL1.4)
  • flow cytometry; human; fig 5a
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, Beckman Coulter TRB antibody (Immunotech, ELL1.4) was used in flow cytometry on human samples (fig 5a). Cell Mol Immunol (2017) ncbi
mouse monoclonal (VER2.32.1)
  • flow cytometry; human; fig 5a
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, Beckman Coulter TRB antibody (Immunotech, VER2.32.1) was used in flow cytometry on human samples (fig 5a). Cell Mol Immunol (2017) ncbi
mouse monoclonal (C21)
  • flow cytometry; human
Beckman Coulter TRB antibody (Immunotech, C21) was used in flow cytometry on human samples . Eur J Cancer (2015) ncbi
mouse monoclonal (C21)
  • flow cytometry; human
Beckman Coulter TRB antibody (Beckman Coulter, C21) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (MPB2D5)
  • flow cytometry; human
Beckman Coulter TRB antibody (Beckman Coulter, MPB2D5) was used in flow cytometry on human samples . J Immunol (2014) ncbi
Articles Reviewed
  1. Laffey K, Stiles R, Ludescher M, Davis T, Khwaja S, Bram R, et al. Early expression of mature αβ TCR in CD4-CD8- T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations. Proc Natl Acad Sci U S A. 2022;119:e2118529119 pubmed publisher
  2. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed publisher
  3. Chiou S, Tseng D, Reuben A, Mallajosyula V, Molina I, Conley S, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021;54:586-602.e8 pubmed publisher
  4. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed publisher
  5. Saliba D, Céspedes Donoso P, Balint S, Compeer E, Korobchevskaya K, Valvo S, et al. Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells. elife. 2019;8: pubmed publisher
  6. Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed publisher
  7. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed publisher
  8. Poncette L, Chen X, Lorenz F, Blankenstein T. Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression. J Clin Invest. 2019;129:324-335 pubmed publisher
  9. Zhu L, Xie X, Zhang L, Wang H, Jie Z, Zhou X, et al. TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival. Nat Commun. 2018;9:2812 pubmed publisher
  10. Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, et al. CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers. Sci Immunol. 2018;3: pubmed publisher
  11. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed publisher
  12. Liang W, Mao S, Sun S, Li M, Li Z, Yu R, et al. Core Fucosylation of the T Cell Receptor Is Required for T Cell Activation. Front Immunol. 2018;9:78 pubmed publisher
  13. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed publisher
  14. Matos T, O Malley J, Lowry E, Hamm D, Kirsch I, Robins H, et al. Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing ?? T cell clones. J Clin Invest. 2017;127:4031-4041 pubmed publisher
  15. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed publisher
  16. Gordon S, Maute R, Dulken B, Hutter G, George B, McCracken M, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017;545:495-499 pubmed publisher
  17. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed publisher
  18. Van Caeneghem Y, De Munter S, Tieppo P, Goetgeluk G, Weening K, Verstichel G, et al. Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. Oncoimmunology. 2017;6:e1283460 pubmed publisher
  19. Miyata Takata T, Takata K, Kato S, Hu L, Noujima Harada M, Chuang S, et al. Clinicopathological analysis of primary central nervous system NK/T cell lymphoma: rare and localized aggressive tumour among extranasal NK/T cell tumours. Histopathology. 2017;71:287-295 pubmed publisher
  20. Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed publisher
  21. Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592 pubmed
  22. Komdeur F, Wouters M, Workel H, Tijans A, Terwindt A, Brunekreeft K, et al. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Oncotarget. 2016;7:75130-75144 pubmed publisher
  23. Jung Y, Riven I, Feigelson S, Kartvelishvily E, Tohya K, Miyasaka M, et al. Three-dimensional localization of T-cell receptors in relation to microvilli using a combination of superresolution microscopies. Proc Natl Acad Sci U S A. 2016;113:E5916-E5924 pubmed
  24. Rosskopf S, Jutz S, Neunkirchner A, Candia M, Jahn Schmid B, Bohle B, et al. Creation of an engineered APC system to explore and optimize the presentation of immunodominant peptides of major allergens. Sci Rep. 2016;6:31580 pubmed publisher
  25. Henry E, Sy C, Inclan Rico J, Espinosa V, Ghanny S, Dwyer D, et al. Carbonic anhydrase enzymes regulate mast cell-mediated inflammation. J Exp Med. 2016;213:1663-73 pubmed publisher
  26. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  27. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed publisher
  28. Veinotte L, Gebremeskel S, Johnston B. CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFN? production and tumor control. Oncoimmunology. 2016;5:e1160979 pubmed publisher
  29. Fransén Pettersson N, Duarte N, Nilsson J, Lundholm M, Mayans S, Larefalk A, et al. A New Mouse Model That Spontaneously Develops Chronic Liver Inflammation and Fibrosis. PLoS ONE. 2016;11:e0159850 pubmed publisher
  30. Moura J, Rodrigues J, Goncalves M, Amaral C, Lima M, Carvalho E. Impaired T-cell differentiation in diabetic foot ulceration. Cell Mol Immunol. 2017;14:758-769 pubmed publisher
  31. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  32. Fuchs T, Hahn M, Riabov V, Yin S, Kzhyshkowska J, Busch S, et al. A combinatorial αβ T cell receptor expressed by macrophages in the tumor microenvironment. Immunobiology. 2017;222:39-44 pubmed publisher
  33. Louie C, DiMaio M, Matsukuma K, Coutre S, Berry G, Longacre T. Idelalisib-associated Enterocolitis: Clinicopathologic Features and Distinction From Other Enterocolitides. Am J Surg Pathol. 2015;39:1653-60 pubmed publisher
  34. Feige M, Behnke J, Mittag T, Hendershot L. Dimerization-dependent folding underlies assembly control of the clonotypic αβT cell receptor chains. J Biol Chem. 2015;290:26821-31 pubmed publisher
  35. Owens G, Erickson K, Malone C, Pan C, Huynh M, Chang J, et al. Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis. J Neuroinflammation. 2015;12:134 pubmed publisher
  36. Oberg H, Kellner C, Gonnermann D, Peipp M, Peters C, Sebens S, et al. γδ T cell activation by bispecific antibodies. Cell Immunol. 2015;296:41-9 pubmed publisher
  37. Takata K, Noujima Harada M, Miyata Takata T, Ichimura K, Sato Y, Miyata T, et al. Clinicopathologic analysis of 6 lymphomatoid gastropathy cases: expanding the disease spectrum to CD4-CD8+ cases. Am J Surg Pathol. 2015;39:1259-66 pubmed publisher
  38. Jeon Y, Kim J, Sung J, Han J, Ko Y. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features. Hum Pathol. 2015;46:981-90 pubmed publisher
  39. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  40. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed publisher
  41. Renauer P, Coit P, Sawalha A. The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response. Clin Immunol. 2015;156:19-27 pubmed publisher
  42. Wang L, Wang G, Gao T. Acneiform primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoma with prominent necrosis. J Cutan Pathol. 2015;42:265-70 pubmed publisher
  43. Lester L, Ewalt M, Warnke R, Kim J. Systemic panniculitis-like T-cell lymphoma with involvement of mesenteric fat and subcutis. J Cutan Pathol. 2015;42:46-9 pubmed publisher
  44. Freeman A, Bridge J, Maruthayanar P, Overgaard N, Jung J, Simpson F, et al. Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage. PLoS ONE. 2014;9:e110928 pubmed publisher
  45. Gibbons D, Fleming P, Virasami A, Michel M, Sebire N, Costeloe K, et al. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat Med. 2014;20:1206-10 pubmed publisher
  46. Takata K, Hong M, Sitthinamsuwan P, Loong F, Tan S, Liau J, et al. Primary cutaneous NK/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia. Am J Surg Pathol. 2015;39:1-12 pubmed publisher
  47. Yamaguchi M, Takata K, Yoshino T, Ishizuka N, Oguchi M, Kobayashi Y, et al. Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy. Cancer Sci. 2014;105:1435-41 pubmed publisher
  48. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  49. Onaindia A, Montes Moreno S, Rodriguez Pinilla S, Batlle A, Gonzalez de Villambrosia S, Rodriguez A, et al. Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features. Histopathology. 2015;66:846-55 pubmed publisher
  50. Takahashi Y, Takata K, Kato S, Sato Y, Asano N, Ogino T, et al. Clinicopathological analysis of 17 primary cutaneous T-cell lymphoma of the ?? phenotype from Japan. Cancer Sci. 2014;105:912-23 pubmed publisher
  51. Helm O, Mennrich R, Petrick D, Goebel L, Freitag Wolf S, Roder C, et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS ONE. 2014;9:e94357 pubmed publisher
  52. Tarbox J, Keppel M, Topcagic N, Mackin C, Ben Abdallah M, Baszis K, et al. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol. 2014;34:594-9 pubmed publisher
  53. Leimgruber A, Ferber M, Irving M, Hussain Kahn H, Wieckowski S, Derre L, et al. TCRep 3D: an automated in silico approach to study the structural properties of TCR repertoires. PLoS ONE. 2011;6:e26301 pubmed publisher
  54. Lee D, Yang J, Lee S, Won C, Chang S, Lee M, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinical and pathologic study of 14 korean patients. Ann Dermatol. 2011;23:329-37 pubmed publisher